2022 in, Sinopharm Engineering adhered to the development concept of "value creation as the goal and technological innovation as the driving force", fully implemented the "Outline of the 14th Five-Year Development Plan of China Pharmaceutical Group United Engineering Co., Ltd.", and implemented in-depth scientific and technological innovation strategies. Increasing investment in science and technology, focusing on building a source of scientific and technological innovation in the field of pharmaceutical engineering construction, scientific and technological innovation has achieved fruitful results.

"Research on Digital Delivery Methods and Standards of Pharmaceutical Industry Construction Projects" is a key scientific research project of Sinopharm Engineering during the "14th Five-Year Plan" period. The project takes the factory object as the core, intelligent PID based on the application of information technology, the engineering design, procurement, construction and other information into structured data and unstructured data, the establishment of data organization model, the use of computer expression, transmission and processing. The research of this project fills the gap in the field of domestic pharmaceutical engineering construction, and the research results are of great significance to the company's digital transformation, the development of digital business, the implementation of life cycle equipment management for pharmaceutical enterprises, the construction of digital factories and intelligent factories, and the promotion of high-quality development of the pharmaceutical industry and pharmaceutical engineering construction industry.2022 year11 month24 the project passed the acceptance review by authoritative experts in the industry.

The Ministry of Industry and Information Technology "Fermentation Wastewater and Bacterial Residue Treatment Technology Project" jointly undertaken by Sinopharm Engineering, Shanghai Medical Institute and Shanghai Jiaotong University has passed two years of research and has established a comprehensive treatment of fermentation pharmaceutical production wastewater and bacterial residue And testing platform, including self-designed and built300L multistage anaerobic/ facultative anaerobic/ good growth coupling multi-stage reflux bioreactor,200L exhaust gas integrated treatment unit,200L integrated aerobic bioaugmentation reactor and related supporting testing facilities. The results of the project have been successfully applied in the wastewater treatment demonstration project of Zhuhai Rundu Pharmaceutical Co., Ltd., Rundu Pharmaceutical (Jingmen) Co., Ltd. and the solid waste residue treatment demonstration project of Inner Mongolia Puin Pharmaceutical Co., Ltd., achieving standard discharge.

The "Efficient Intelligent Computer Room Energy Efficiency Control System" project implements intelligent and modular control through tracking and forecasting of terminal load, combined with the load efficiency characteristics of chillers, to achieve integrated optimization and unmanned, data-based and information-based operation management. The results of this project will be the operating efficiency of the refrigeration station system.

in addition,2022 national Pharmaceutical Engineering Patent Authorization in27 piece, in which the invention patent1 pieces.1 patents to achieve product transformation.

Technology never ends, innovation never stops. In the next step, the National Pharmaceutical Project will further focus on scientific and technological innovation, strengthen key core technology research, and provide strong technical support for the high-quality development of the National Pharmaceutical Project while building core competitiveness.

(Contribution of Engineering Technology Department)